Hence, we undertook this meta-analysis, which supported that GSTM1 gene polymorphism was associated with laryngeal cancer and suggested that GSTM1 null genotype had an effect on the risk of developing laryngeal cancer among Caucasians. This evidence concerns the gene GSTM1 and laryngeal carcinoma.